Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Javid Fazili and Mohammad Madhoun.
Connection Strength

0.307
  1. Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014 May 14; 20(18):5442-60.
    View in: PubMed
    Score: 0.119
  2. Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis. Am J Med Sci. 2010 Feb; 339(2):169-73.
    View in: PubMed
    Score: 0.089
  3. Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis. Eur J Gastroenterol Hepatol. 2018 Mar; 30(3):296-301.
    View in: PubMed
    Score: 0.039
  4. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Oncotarget. 2015 Nov 10; 6(35):37200-15.
    View in: PubMed
    Score: 0.033
  5. A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients. J Viral Hepat. 2013 Sep; 20(9):622-7.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.